This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
8/7/2023
Operator
Conference Operator
Good morning, ladies and gentlemen, and welcome to the Protolix Biotherapeutics Conference, second quarter and 2023 financial business results. As a reminder, this conference is being recorded. I will now turn the conference over to our host, Mr. Chuck Badala, with LifeSite Advisors, Investor Relations for Protolix. Thank you. You may begin the conference.
Chuck Badala
Investor Relations, LifeSite Advisors
Thank you, Operator, and welcome to the Portalix Biotherapeutics Second Quarter 2023 Financial Results and Business Update Conference Call. With me today are Dror Bishan, President and CEO of Portalix, and Eyal Rubin, Senior Vice President and Chief Financial Officer. A press release announcing the results and the update was issued this morning and is available now on the Portalix website. Please take a moment to read the disclaimer about forward-looking statements in the press release. The earnings release and this teleconference include forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from the statements made. Factors that could cause actual results to differ are described in the disclaimer and in the portalics filings with the U.S. Security and Exchange Commission.
Chuck Badala
Investor Relations, LifeSite Advisors
I will now turn the call over to Mr. Dror Bashan. Dror?
You're reading a preview of the PLX Q2 2023 earnings call.
Free account.
Disclaimer